# Focus-X Therapeutics, Inc. — Form D

Focus-X Therapeutics, Inc. of SAMMAMISH, WA, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-22. The offering totals $3.0M, of which $1.5M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2020-09-22
- Form: D
- Accession: 0001567619-20-016966
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $1.5M
- Remaining: $1.5M
- Investors: 1
- Date of first sale: 2020-09-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-375977

## Issuer

- Name: Focus-X Therapeutics, Inc.
- CIK: 0001825529
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3541 223RD AVE. SE., SAMMAMISH, WA, 98075
- Phone: 3175694884

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Qi Hui | Director | Sammamish, WA |
| Fa Liu | Director | Sammamish, WA |
| Qi Hui | Executive Officer | Sammamish, WA |
| Fa Liu | Executive Officer | Sammamish, WA |

## More

- [CIK 1825529 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1825529&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001567619-20-016966.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.